QuidelOrtho Corporation (QDEL) has a MoatMap StockRank of 28/100 based on Quality (34/100), Value (61/100), and Momentum (21/100) factor scores. The current signal is SELL. QuidelOrtho is a diagnostic healthcare company. It is currently suffering from a severe post-COVID demand cliff and high debt levels, making it a turnaround story which violates our Terry Smith quality lens.
QuidelOrtho Corporation is a global diagnostic company that develops, manufactures, and markets innovative diagnostic solutions for point-of-care, laboratory, and transfusion medicine applications. Its competitive moat is built upon a broad portfolio of proprietary diagnostic platforms, extensive R&D capabilities, and established global distribution channels, particularly in infectious disease testing and clinical labs. Formed from a significant merger, QuidelOrtho is a major player offering critical diagnostic tools to healthcare systems worldwide.
| Price | $13.94 |
| Market Cap | $891M |
| P/E (Forward) | 6.27 |
| Price/Book | 0.56 |
| Return on Equity | -49.9% |
| Return on Invested Capital | -19.2% |
| Debt/Equity | 155.27 |
| Gross Margin | 45.2% |
| Operating Margin | -4.1% |
| Revenue Growth | -10.5% |
| Free Cash Flow | $209M |
QuidelOrtho Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).